The case for cancer-associated fibroblasts: essential elements in cancer drug discovery?
{{output}}
Although cancer-associated fibroblasts (CAFs) have gained increased attention for supporting cancer progression, current CAF-targeted therapeutic options are limited and failing in clinical trials. As the largest component of the tumor microenvironment (TME), ... ...
